Stem-Cell Research
Stem cells derived via nuclear transplantation regenerates infarcted heart
Published in Blood Weekly, June 10th, 2004
According to a study from New York Medical College, "Nuclear transfer techniques have been proposed as a strategy for generating an unlimited supply of rejuvenated and histocompatible stem cells for the treatment of cardiac diseases.
"For this purpose, c-kit -positive fetal liver stem cells obtained from cloned embryos were injected in the border zone of infarcted mice to induce tissue reconstitution. Cloned embryos were derived from somatic cell fusion between nuclei of cultured LacZ-positive fibroblasts and enucleated oocytes of a different mouse strain."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-06-10)
More Articles from Blood Weekly
- Cell Proliferation
Hepatocyte proliferation enhanced by immobilization on 24 nm-sized gold colloid - Stem-Cell Research
Genetic profiling of hair follicle stem cells yields treatment targets - Stem-Cell Transplantation
IFN with very low-dose PBMC infusion induces complete remission in CML relapse - Tissue Engineering
Schwann cells implanted into acellular muscle provides graft for regeneration - Acute Coronary Syndromes
Company announces reinitiation of phase IIa trial in ACS - Acute Myeloid Leukemia
Ceplene trial in AML meets primary trial endpoint - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
